William Lis - Net Worth and Insider Trading
William Lis Net Worth
The estimated net worth of William Lis is at least $6 Million dollars as of 2024-11-13. William Lis is the CEO of Portola Pharmaceuticals Inc and owns about 222,035 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $4 Million. William Lis is the Director of Zai Lab Ltd and owns about 53,089 shares of Zai Lab Ltd (ZLAB) stock worth over $2 Million. William Lis is also the Director of Jasper Therapeutics Inc and owns about 5,352 shares of Jasper Therapeutics Inc (JSPR) stock worth over $128,073. Details can be seen in William Lis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Lis has not made any transactions after 2024-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Lis
William Lis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Lis owns 4 companies in total, including Eidos Therapeutics Inc (EIDX) , Portola Pharmaceuticals Inc (PTLA) , and Zai Lab Ltd (ZLAB) among others .
Click here to see the complete history of William Lis’s form 4 insider trades.
Insider Ownership Summary of William Lis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2020-05-27 | director |
| PTLA | Portola Pharmaceuticals Inc | 2018-07-28 | director & Chief Executive Officer |
| ZLAB | Zai Lab Ltd | 2024-07-01 | director |
 | | 2023-10-13 | director |
William Lis Latest Holdings Summary
William Lis currently owns a total of 3 stocks. Among these stocks, William Lis owns 222,035 shares of Portola Pharmaceuticals Inc (PTLA) as of June 6, 2018, with a value of $4 Million and a weighting of 70.62%. William Lis owns 53,089 shares of Zai Lab Ltd (ZLAB) as of July 1, 2024, with a value of $2 Million and a weighting of 27.12%. William Lis also owns 5,352 shares of Jasper Therapeutics Inc (JSPR) as of October 13, 2023, with a value of $128,073 and a weighting of 2.26%.
Latest Holdings of William Lis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTLA | Portola Pharmaceuticals Inc | 2018-06-06 | 222,035 | 18.03 | 4,003,291 |
| ZLAB | Zai Lab Ltd | 2024-07-01 | 53,089 | 28.96 | 1,537,457 |
| JSPR | Jasper Therapeutics Inc | 2023-10-13 | 5,352 | 23.93 | 128,073 |
Holding Weightings of William Lis
William Lis Form 4 Trading Tracker
According to the SEC Form 4 filings, William Lis has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 5,113 shares on June 6, 2018, which brought William Lis around $231,159.
According to the SEC Form 4 filings, William Lis has made a total of 2 transactions in Zai Lab Ltd (ZLAB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zai Lab Ltd is the sale of 10,397 shares on July 1, 2024, which brought William Lis around $180,076.
According to the SEC Form 4 filings, William Lis has made a total of 3 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Jasper Therapeutics Inc is the sale of 797 shares on October 13, 2023, which brought William Lis around $6,770.
Insider Trading History of William Lis
- 1
William Lis Trading Performance
William Lis Ownership Network
Ownership Network List of William Lis
Ownership Network Relation of William Lis
William Lis Owned Company Details
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
William Lis is the director of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
William Lis Mailing Address
Above is the net worth, insider trading, and ownership report for William Lis. You might contact William Lis via mailing address: Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
